Read news on drug conjugate with our app.
Read more in the app
ASCO: New antibody-drug conjugate shows promising safety and response rates for patients with rare blood cancer - EurekAlert!
ASCO: HER3-targeted antibody-drug conjugate (ADC) shows promise for treatment-resistant solid tumors - EurekAlert!
Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer
Antibody-drug conjugate found effective against brain metastases in patients with HER2-positive breast cancer - EurekAlert
